STEPHANIE HETZEL: Open Payments
NPI 1548955685 · COLORADO SPRINGS, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$521 in 17 payments from 8 companies in 2025. Trend: 2023 $623 · 2024 $55 · 2025 $521
Food & beverage: $521
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 2 | $139 |
| Neurocrine BioSciences, Inc. | 2 | $122 |
| Alkermes, Inc. | 5 | $97 |
| Lundbeck LLC | 2 | $47 |
| Otsuka America Pharmaceutical, Inc. | 2 | $43 |
| Teva Pharmaceuticals USA, Inc. | 2 | $34 |
| Indivior Inc. | 1 | $23 |
| E.R. Squibb & Sons, L.L.C. | 1 | $15 |
Products named: INGREZZA, FANAPT, REXULTI, ARISTADA, VIVITROL, AUSTEDO XR, SUBLOCADE, HETLIOZ.
Industry payments across CO — which companies pay providers there.
